Blood test in early pregnancy could warn of dangerous conditions
NCT ID NCT01490489
First seen Nov 18, 2025 · Last updated Jun 16, 2026 · Updated 28 times
Summary
This study looked at whether measuring a protein called EG-VEGF in the blood of pregnant women between 14 and 18 weeks could help predict pre-eclampsia or intrauterine growth restriction (poor fetal growth). Researchers enrolled 142 women and measured EG-VEGF levels, comparing them to pregnancy outcomes. The goal is to find a simple blood test that flags high-risk pregnancies early, allowing for closer monitoring and better care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical investigation center of the Grenoble University Hospital
Grenoble, Isere, 38043, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.